These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37789785)

  • 1. Unraveling the complexity: A comprehensive analysis of the PP2A in cancer and its potential for novel targeted therapies.
    Ivovič D; Kabelíková P; Jurkovičová D
    Neoplasma; 2023 Aug; 70(4):485-499. PubMed ID: 37789785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic targeting of PP2A.
    O'Connor CM; Perl A; Leonard D; Sangodkar J; Narla G
    Int J Biochem Cell Biol; 2018 Mar; 96():182-193. PubMed ID: 29107183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting PP2A in cancer: Combination therapies.
    Mazhar S; Taylor SE; Sangodkar J; Narla G
    Biochim Biophys Acta Mol Cell Res; 2019 Jan; 1866(1):51-63. PubMed ID: 30401535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase.
    Sangodkar J; Farrington CC; McClinch K; Galsky MD; Kastrinsky DB; Narla G
    FEBS J; 2016 Mar; 283(6):1004-24. PubMed ID: 26507691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biased holoenzyme assembly of protein phosphatase 2A (PP2A): From cancer to small molecules.
    Haanen TJ; O'Connor CM; Narla G
    J Biol Chem; 2022 Dec; 298(12):102656. PubMed ID: 36328247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PP2A subunit PR130 is a key regulator of cell development and oncogenic transformation.
    Dzulko M; Pons M; Henke A; Schneider G; Krämer OH
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188453. PubMed ID: 33068647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer.
    Seshacharyulu P; Pandey P; Datta K; Batra SK
    Cancer Lett; 2013 Jul; 335(1):9-18. PubMed ID: 23454242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein phosphatase 2A: a target for anticancer therapy.
    Perrotti D; Neviani P
    Lancet Oncol; 2013 May; 14(6):e229-38. PubMed ID: 23639323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of SET and protein phosphatase 2A as target for cancer therapy.
    Dacol EC; Wang S; Chen Y; Lepique AP
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188578. PubMed ID: 34116173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potential.
    Hong CS; Ho W; Zhang C; Yang C; Elder JB; Zhuang Z
    Cancer Biol Ther; 2015; 16(6):821-33. PubMed ID: 25897893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role and therapeutic potential of Ser/Thr phosphatase PP2A in apoptotic signalling networks in human cancer cells.
    Janssens V; Rebollo A
    Curr Mol Med; 2012 Mar; 12(3):268-87. PubMed ID: 22300139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PP2A as a potential therapeutic target for breast cancer: Current insights and future perspectives.
    Qi Y; Li L; Wei Y; Ma F
    Biomed Pharmacother; 2024 Apr; 173():116398. PubMed ID: 38458011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation and role of the PP2A-B56 holoenzyme family in cancer.
    Peris I; Romero-Murillo S; Vicente C; Narla G; Odero MD
    Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188953. PubMed ID: 37437699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PP2A and tumor radiotherapy.
    Lei X; Ma N; Du L; Liang Y; Zhang P; Han Y; Qu B
    Hereditas; 2020 Aug; 157(1):36. PubMed ID: 32847617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
    Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
    BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PP2A-B55 Holoenzyme Regulation and Cancer.
    Goguet-Rubio P; Amin P; Awal S; Vigneron S; Charrasse S; Mechali F; Labbé JC; Lorca T; Castro A
    Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33266510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein Phosphatase 2A: a Double-Faced Phosphatase of Cellular System and Its Role in Neurodegenerative Disorders.
    Nematullah M; Hoda MN; Khan F
    Mol Neurobiol; 2018 Feb; 55(2):1750-1761. PubMed ID: 28224476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles and regulation of protein phosphatase 2A (PP2A) in the heart.
    Lubbers ER; Mohler PJ
    J Mol Cell Cardiol; 2016 Dec; 101():127-133. PubMed ID: 27832939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting PP2A for cancer therapeutic modulation.
    Ronk H; Rosenblum JS; Kung T; Zhuang Z
    Cancer Biol Med; 2022 Nov; 19(10):1428-39. PubMed ID: 36342229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic relevance of the protein phosphatase 2A in cancer.
    Cunningham CE; Li S; Vizeacoumar FS; Bhanumathy KK; Lee JS; Parameswaran S; Furber L; Abuhussein O; Paul JM; McDonald M; Templeton SD; Shukla H; El Zawily AM; Boyd F; Alli N; Mousseau DD; Geyer R; Bonham K; Anderson DH; Yan J; Yu-Lee LY; Weaver BA; Uppalapati M; Ruppin E; Sablina A; Freywald A; Vizeacoumar FJ
    Oncotarget; 2016 Sep; 7(38):61544-61561. PubMed ID: 27557495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.